FEMA | N/A |
CAS | 98319-26-7 |
EINECS | N/A |
JECFA Food Flavoring | N/A |
CoE Number | N/A |
Organoleptic Notes |
|
Odor | N/A |
Flavor | N/A |
Material Notes | an orally active 3-oxo-5-alpha-steroid 4-dehydrogenase inhibitor. it is used as a surgical alternative for treatment of benign prostatic hyperplasia. Finasteride is an androgen antagonist. Finasteride is one of the currently available pharmacologic treatment modalities with proven efficacy for treatment of androgenetic alopecia. Androgenetic alopecia (AGA), or male pattern hair loss, affects approximately 50% of the male population. AGA is an androgen-related condition in genetically predisposed individuals. There is no treatment to completely reverse AGA in advanced stages, but with medical treatment (e.g., finasteride), the progression can be arrested and partly reversed in the majority of patients who have mild to moderate AGA. Finasteride may increase the sensitivity of prostate specific antigen to detect prostate cancer. At present, finasteride remains the only intervention shown in long-term prospective phase III clinical trials to reduce the incidence of prostate cancer. (PMID: 18044109, 17543725, 17414641, 17415094, 17394699) [HMDB] |